Pharmaceuticals

Non-Therapeutic Biomolecules Market Expansion to $51.03 Billion by 2029: Key Drivers and Trends

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the non-therapeutic biomolecules market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Non-Therapeutic Biomolecules Market Today And What Will It Reach By 2029?

The non-therapeutic biomolecules market has experienced substantial growth in recent years. It is projected to expand from $30.76 billion in 2024 to $33.92 billion in 2025, at a compound annual growth rate (CAGR) of 10.3%. This historical growth can be attributed to increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, and regulatory support.

The non-therapeutic biomolecules market is projected to experience swift expansion in the coming years. Its valuation is anticipated to reach $51.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.8%. This expansion during the forecast period is driven by factors such as emerging market avenues, progress in data analytics and integration, an increasing emphasis on precision medicine, greater investment in personalized healthcare, and a broadening of application domains. Key developments expected over this period encompass technological innovations, strategic alliances, an increase in agricultural applications, a widening influence in industrial processes, and an emphasis on customization and personalization.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What Factors Are Boosting The Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market is anticipated to expand due to the escalating volume of research and laboratory examinations. Laboratory testing, a medical process, involves analyzing bodily samples such as blood or urine to diagnose and track diseases and formulate treatment strategies. Concurrently, research involves generating novel knowledge or innovatively applying existing knowledge to develop new concepts, theories, and comprehensive understandings. Within laboratory tests, non-therapeutic biomolecules are employed to gauge the existence or density of biomarker molecules indicative of illness, thereby improving the tests’ sensitivity and specificity. A notable illustration is provided by the National Health Service (NHS), a healthcare provider in the UK, which reported in July 2024 that diagnostic operations surpassed pre-pandemic volumes in 2023, with tests conducted in May 2024 showing a 21% rise over the preceding year. Consequently, this upsurge in research initiatives and laboratory assessments is a primary catalyst for the expansion of the non-therapeutic biomolecules market.

How Is The Non-Therapeutic Biomolecules Market Categorized By Application, Type, And Region?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

How Are Technological Trends Affecting The Non-Therapeutic Biomolecules Market Growth?

A significant and emerging trend within the non-therapeutic biomolecules market is the rise of product innovations. Leading firms in this sector are concentrating their efforts on research and development for novel products to maintain their competitive standing. As an illustration, in January 2022, BASF SE, a German multinational chemical enterprise, collaborated with Caregen, a Korean company specializing in biomimetic peptide research and development. Together, they launched the Peptovitae series, developed with liposome-encapsulation technology, aiming to broaden BASF SE’s dermo-cosmetics offerings and provide unique, advanced solutions for various skin issues. Liposomal encapsulation is defined as a method employing fats to deliver vital vitamins or medications in microscopic bubbles directly to target body areas, thereby avoiding impact on other sections. The Peptovitae series effectively tackles a broader spectrum of skin issues compared to conventional peptide applications, including combating aging indicators, improving skin luminosity, alleviating dryness and itching, and providing hydration.

Who Are The Global Leaders Steering The Non-Therapeutic Biomolecules Market Forward?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2025, By The Business Research Company

Small Animal Imaging In Vivo Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Biologics Market 2025

https://www.thebusinessresearchcompany.com/report/biologics-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795